NCT06408298View on ClinicalTrials.gov

HCQ in Resectable Localized Prostate Cancer

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

October 31, 2028

Study Completion Date

December 31, 2028

Conditions
Resectable Localized Prostate Cancer
Interventions
DRUG

Hydroxychloroquine Sulfate 400Mg Tab

hydroxychloroquine sulfate tablet

DRUG

Placebo

Inactive tablet

All Listed Sponsors
collaborator

Dartmouth Cancer Center

UNKNOWN

lead

Lionel.D.Lewis, MD

OTHER